Speakers - Sachs Associates
Speakers - Sachs Associates
Speakers - Sachs Associates
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CONTACTS<br />
Aaron Powers<br />
President<br />
Dave Reusswig<br />
Vice President<br />
ADDRESS<br />
3820 Ohio Ave, Ste 8-14<br />
St Charles, IL 60174<br />
TELEPHONE<br />
630-400-2135<br />
FAX<br />
480-287-8984<br />
EMAIL<br />
aapowers@mac.com<br />
YEAR FOUNDED<br />
2007<br />
Northern Biotechnologies llc<br />
www.nothernbiotechnologies.com<br />
FINANCIAL SUMMARY<br />
Northern Biotechnologies has raised $1.5M in round “a” private funding. Northern is seeking commercialization<br />
and investment partnerships to continue the development of additional anti-bacterial, antiviral and anti-fungal<br />
applications of our technology which require additional testing, proof of concept and commercialization partners.<br />
COMPANY PROFILE<br />
Northern Biotechnologies is pioneering the commercialization of an innovative, long lasting, therapeutic anti<br />
microbial technology that has significant applications in the Human Health Care arena. Infectious disease control<br />
and prevention can be revolutionized by integration of our cost saving technology. Issued Patents and proprietary<br />
production IP offer a stable platform for growth and partnership into all human related applications of the<br />
technology. A unique feature of the technology is its extended protection of 1-3 days through each application.<br />
Additionally, the physical method of pathogen destruction prevents formation of resistant strain types, in contrast<br />
to existing technologies that rely on metabolic action for kill. Testing shows high performance anti-bacterial,<br />
anti-fungal and antiviral functioning in various direct, topical, and wound care, nasal/ oral and related dosing<br />
mechanisms of the technology. We are in process with the first New Drug Application for antiseptic hand wash,<br />
and are looking for partners to pursue additional drug approvals in specific markets.<br />
Existing product branding in the Human market is Prefense hand sanitizer and wipes. In addition to human<br />
applications, Northern holds over twenty-five global patents for anti-microbial water filtration using our<br />
technology. We also hold EPA registrations for persistent antimicrobial filter media. Significant opportunity exists<br />
in the technology used as a multi surface sanitizer for all levels of food production. Other existing product lines<br />
and cash flow are in place from additional internally developed technologies including high performance filtration<br />
medias, biotech remediation and process technologies used in petroleum, agricultural, and industrial processing.<br />
Northern also holds nationally placed consumer and professional brand lines of “green probiotic” cleaning<br />
products based on our IP and manufacturing base. Additionally, our cGMP contract packaging division sells<br />
our proprietary formulations to many national brands in a variety of markets. Company management is made<br />
of a diverse team with the experience and drive required to steer strong growth and relationships with partner<br />
companies.<br />
MANAGEMENT<br />
Aaron Powers, President<br />
Dave Reusswig, Vice President<br />
Katan & <strong>Associates</strong>, Financial Consultants<br />
t back :: next u<br />
WELCOME PHARMA LICENSING GROUPS<br />
SPEAKERS<br />
PRESENTING COMPANIES SUPPORTING ORGANISATIONS<br />
ORGANISERS